DNLI Stock Price | Denali Therapeutics Inc. Stock Quote (U.S.: Nasdaq)


Denali Therapeutics Inc.

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.



Source link

More from author

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related posts

Advertismentspot_img

Latest posts

Have your preferences changed for what you like in a blush? (If so, how?)

Comments that do not adhere to our comment policy may be removed. Discussion and debate are highly encouraged but we expect community members to participate respectfully. Please...

Metroid Dread Update Now Live, Fixes Progression Bug And Various Other Issues

Update, 10/21/21: Nintendo has released a software update for Metroid Dread that fixes the progression bug it tweeted about last week. It fixes "several other...

Las Vegas can be next new F1 race in America

Oct.21 - Las Vegas, the fabled casino capital of the US, could be the next host to be added to the Formula 1...

Want to stay up to date with the latest news?

We would love to hear from you! Please fill in your details and we will stay in touch. It's that simple!